Jennifer L. Brooks - Concepedia

Author

Jennifer L. Brooks

Biota Pharmaceuticals (United States)

Also Known As

J Brooks, J. L. Brooks, Jennifer Brooks, Jennifer L Brooks, Jennifer L. Brooks

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Biota Pharmaceuticals (United States)University at Albany, State University of New York Albany State University Scripps Research Institute

About

Jennifer L. Brooks is an author at Biota Pharmaceuticals (United States) specializing in medicine, biochemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	427
2	Health Sciences	3	3	161
3	Natural Sciences	3	3	275
4	Education	2	2	131
5	Nursing	1	1	44

Jennifer L. Brooks

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P <sub>1</sub> ) and receptor‐5 (S1P <sub>5</sub> ) agonist with autoimmune disease‐modifying activity Fiona L. Scott, Bryan Clemons, Jennifer L. Brooks, British Journal of Pharmacology	2016	296
Structure−Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase Anne B. Eldrup, Charles Allerson, C. Frank Bennett, Journal of Medicinal Chemistry Medicinal ChemistryViral ReplicationBiochemistryViral Polymerase StructureStructure−activity Relationship	2004	187
Structure−Activity Relationship of Heterobase-Modified 2‘-<i>C</i>-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication Anne B. Eldrup, Marija Prhavc, Jennifer L. Brooks, Journal of Medicinal Chemistry	2004	185
The Pleckstrin Homology Domain in Insulin Receptor Substrate-1 Sensitizes Insulin Signaling Martin G. Myers, Timothy C. Grammer, Jennifer L. Brooks, Journal of Biological Chemistry	1995	115
Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator Jonathan Q. Tran, Jeffrey Hartung, Robert Peach, The Journal of Clinical Pharmacology	2017	106
Experimental studies of welfare reform and children. Martha Zaslow, Kristin Anderson Moore, Jennifer L. Brooks, PubMed Child WelfarePublic WelfareEducationFamily StrengtheningWelfare Economics	2002	91
Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator Sekhar Surapaneni, Usha Yerramilli, April Bai, Drug Metabolism and Disposition	2021	70
Synthesis of AZT 5‘-Triphosphate Mimics and Their Inhibitory Effects on HIV-1 Reverse Transcriptase Guangyi Wang, Nicholas Boyle, Chen Fu, Journal of Medicinal Chemistry Bioorganic ChemistryAzt P3msMolecular BiologyAntiviral DrugChemical Biology	2004	59
Promising Approaches to Engaging Families and Building Strengths in Residential Treatment Amanda B. Nickerson, Frank J. Salamone, Jennifer L. Brooks, Residential Treatment for Children & Youth	2004	46
Family Involvement in Residential Treatment: Staff, Parent, and Adolescent Perspectives Amanda B. Nickerson, Jennifer L. Brooks, Sarah A. Colby, Journal of Child and Family Studies NursingFamily MedicineFamily HealthAdolescent PerspectivesFamily Involvement	2006	44

Page 1